A new working paper provides a practical guide on immunization costing primary data collection and analysis. We would like to invite the Immunization Economics community to explore the working paper and provide feedback
Did you know that the models developed by the DOVE project estimate the costs averted by vaccination? The models focuses on ten antigens and 94 low- and middle-income countries, 2001-2030. Results are used at the global and regional level to advocate for new vaccine introduction and increased coverage.
Public health researchers discuss the importance of making economic evaluations of vaccines AMR-sensitive, outline how this can be done, and offer a roadmap for future research. read more here
Following a call for concept notes last year, the VoVRN Secretariat, members of the Steering Committee, and external expert reviewers identified promising studies to recommend for funding. Learn more about these projects here
An overview of the global policies, potential interventions and strategies related to the integration of immunization services - with guidance and country examples. Read here.
A more efficient, effective and resilient supply chain means more time for health services. A study found 22% more doses delivered following the initiative in the Democratic Republic of Congo. read more here
Learn how countries transitioning from Gavi funding can produce better immunization spending data, and how this data can be analyzed and presented to inform policy and planning. Register here
On Nov 29, connect with Gavi Immunization Finance and Sustainability and Country Program teams. This first webinar will focus on Gavi post-transition support requests. Representatives from Gavi and Moldova will present their work. see more here